These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17336011)

  • 1. [Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].
    Aouam K; Chaabane A; Loussaïef C; Ben Romdhane F; Boughattas NA; Chakroun M
    Med Mal Infect; 2007 May; 37(5):253-61. PubMed ID: 17336011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters.
    Woo J; Chan C; Chan R; Cheung W; Or K; Chan K
    J Med; 1995; 26(5-6):279-94. PubMed ID: 8721904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV; Ovsiankina ES
    Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.
    Durand F; Jebrak G; Pessayre D; Fournier M; Bernuau J
    Drug Saf; 1996 Dec; 15(6):394-405. PubMed ID: 8968694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic problems in the management of elderly patients with tuberculosis.
    Woo J; Chan HS
    Adverse Drug React Toxicol Rev; 1992; 11(1):13-8. PubMed ID: 1606279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications of polychemotherapy for renal tuberculosis].
    Kul'chavenia EV; Kuznetsov PV
    Probl Tuberk; 1998; (1):28-30. PubMed ID: 9553430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular side effects of antitubercular drugs - a focus on prevention, early detection and management.
    Kokkada SB; Barthakur R; Natarajan M; Palaian S; Chhetri AK; Mishra P
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):438-41. PubMed ID: 16449853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The adverse reactions of anti-tuberculosis drugs and its management].
    Wada M
    Nihon Rinsho; 1998 Dec; 56(12):3091-5. PubMed ID: 9883616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Managing the adverse events of antitubercular agents].
    Perriot J; Chambonnet E; Eschalier A
    Rev Mal Respir; 2011 Apr; 28(4):542-55. PubMed ID: 21549908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
    Tostmann A; Boeree MJ; Aarnoutse RE; de Lange WC; van der Ven AJ; Dekhuijzen R
    J Gastroenterol Hepatol; 2008 Feb; 23(2):192-202. PubMed ID: 17995946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113
    [No Abstract]   [Full Text] [Related]  

  • 14. [Desensitization therapy for antituberculous drugs].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Sep; 75(9):521-6. PubMed ID: 11068368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral poly(lactide-co-glycolide) nanoparticle based antituberculosis drug delivery: toxicological and chemotherapeutic implications.
    Pandey R; Sharma S; Khuller GK
    Indian J Exp Biol; 2006 Jun; 44(6):459-67. PubMed ID: 16784116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma.
    Hmouda H; Laouani-Kechrid C; Nejib Karoui M; Denguezli M; Nouira R; Ghannouchi G
    Ann Pharmacother; 2005 Jan; 39(1):165-8. PubMed ID: 15546942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid associated, painful, bilateral gynaecomastia.
    Khanna P; Panjabi C; Maurya V; Shah A
    Indian J Chest Dis Allied Sci; 2003; 45(4):277-9. PubMed ID: 12962465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
    Kocabay G; Erelel M; Tutkun IT; Ecder T
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.